Jiasheng Tu
Affiliations: | Department of Pharmaceutics | China Pharmaceutical University |
Google:
"Jiasheng Tu"Mean distance: (not calculated yet)
Parents
Sign in to add mentorBhaskara Rao Jasti | grad student | 2002-2003 | University of the Pacific |
Xiaoling Li | post-doc | University of the Pacific |
Children
Sign in to add traineeChunmeng Sun | grad student | 2011-2014 | China Pharmaceutical University |
Arpan Mahanty | grad student | 2014-2017 | China Pharmaceutical University |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Zhou M, Wu Y, Sun M, et al. (2023) Spatiotemporally sequential delivery of biomimetic liposomes potentiates glioma chemotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Chen Q, Sun M, Li Y, et al. (2023) Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 102693 |
Ni Y, Zhao W, Cheng W, et al. (2022) Lipopeptide liposomes-loaded hydrogel for multistage transdermal chemotherapy of melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 351: 245-254 |
Wang S, Zhang J, Li W, et al. (2022) Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy. Carbohydrate Polymers. 296: 119940 |
Chen Q, Li Y, Zhou S, et al. (2022) Sequentially sustained release of anticarcinogens for postsurgical chemoimmunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 350: 803-814 |
Zhang Y, Tian S, Huang L, et al. (2022) Reactive oxygen species-responsive and Raman-traceable hydrogel combining photodynamic and immune therapy for postsurgical cancer treatment. Nature Communications. 13: 4553 |
Chen Q, Zhou S, Ding Y, et al. (2022) A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 346: 212-225 |
Huang L, Zhang Y, Li Y, et al. (2021) Time-Programmed Delivery of Sorafenib and Anti-CD47 Antibody via a Double-Layer-Gel Matrix for Postsurgical Treatment of Breast Cancer. Nano-Micro Letters. 13: 141 |
Ye Z, Zhang Y, Liu Y, et al. (2021) EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. International Journal of Nanomedicine. 16: 2443-2459 |
Yu Y, Zu C, He D, et al. (2020) pH-dependent reversibly activatable cell-penetrating peptides improve the antitumor effect of artemisinin-loaded liposomes. Journal of Colloid and Interface Science |